FGF21 increases the sensitivity of sorafenib to hepatocellular carcinoma under hypoxia
{{custom_author.name}}, {{article.zuoZheEn}}
FGF21 increases the sensitivity of sorafenib to hepatocellular carcinoma under hypoxia
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
ADS
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |